These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 91023)

  • 1. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG
    Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG
    Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD; Tessari P; Go VL; Gerich JE
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.
    O'Dea K; Turton J
    Am J Clin Nutr; 1985 Mar; 41(3):511-6. PubMed ID: 3883743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glycoside-hydrolase inhibitor in treatment of dumping syndrome.
    McLoughlin JC; Buchanan KD; Alam MJ
    Lancet; 1979 Sep; 2(8143):603-5. PubMed ID: 90270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
    Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia.
    Jenkins DJ; Goff DV; Leeds AR; Alberti KG; Wolever TM; Gassull MA; Hockaday TD
    Lancet; 1976 Jul; 2(7978):172-4. PubMed ID: 73796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guar flour in the treatment of diabetes mellitus].
    Porciatti F
    G Clin Med; 1979 Nov; 60(11):927-30. PubMed ID: 232683
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of unabsorbable carbohydrate on gut hormones. Modification of post-prandial GIP secretion by guar.
    Morgan LM; Goulder TJ; Tsiolakis D; Marks V; Alberti KG
    Diabetologia; 1979 Aug; 17(2):85-9. PubMed ID: 488570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
    Schöffling K; Hillebrand I
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844
    [No Abstract]   [Full Text] [Related]  

  • 14. Guar gum, dietary fiber and diabetes.
    Med Lett Drugs Ther; 1979 Jun; 21(12):51-2. PubMed ID: 449840
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Thomas G; Puls W
    Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guar gum is not a panacea in diabetes management.
    Carroll DG; Dykes V; Hodgson W
    N Z Med J; 1981 May; 93(683):292-4. PubMed ID: 6265843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
    Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
    Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary guar gum improves insulin sensitivity in streptozotocin-induced diabetic rats.
    Cameron-Smith D; Habito R; Barnett M; Collier GR
    J Nutr; 1997 Feb; 127(2):359-64. PubMed ID: 9039840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
    Gérard J; Luyckx AS; Lefebvre PJ
    Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses.
    Requejo F; Uttenthal LO; Bloom SR
    Diabet Med; 1990 Jul; 7(6):515-20. PubMed ID: 2163805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.